← Evidence map

ArticleMolecular cancer therapeutics2012

REST is a novel prognostic factor and therapeutic target for medulloblastoma.

Pete Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22848092